China Biologic Products Announces First Quarter 2008 Results Conference Call

May 15, 2008

TAI'AN CITY, Shandong, China, May 15 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC: CBPO) (BULLETIN BOARD: CBPO) (''CBP'', ''the Company''), one of the leading plasma-based pharmaceutical companies in the People's Republic of China (''PRC''), today announced that it will conduct a conference call at 5:00 p.m. Eastern Time on Thursday, May 15, 2008 to discuss the first quarter 2008 results.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 800 688 0796. International callers should dial 617 614 4070. When prompted by the operator, mention Conference Passcode 991 762 11.

If you are unable to participate in the call at this time, a replay will be available for fourteen days starting on Thursday, May 15 at 7:00 p.m. Eastern Time. To access the replay, dial 888-286-8010, international callers should dial 617-801-6888, and enter the passcode 533 752 43.

About China Biologic Products, Inc.

China Biologic Products, Inc., through its indirect majority-owned subsidiary Shandong Taibang, is currently the only plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province with a population of 93 million. The company is engaged primarily in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Plasma-based Human Albumin is used mainly to increase blood volume while Immunoglobulin is used for disease prevention and treatment.

  For more information, please contact:

  Company Contact:
   Mr. Stanley Wong
   China Biologic Products, Inc.
   Tel:   +86-538-620-2306

  Investor Relations Contact:
   Mr. Crocker Coulson
   CCG Elite Investor Relations
   Tel:   +1-646-213-1915 (NY office)

SOURCE: China Biologic Products, Inc.

CONTACT: Company Contact: Mr. Stanley Wong, CEO of China Biologic
Products, Inc., +86-538-620-2306, or; or Investor
Relations Contact, Mr. Crocker Coulson, President of CCG Elite Investor
Relations, +1-646-213-1915 (NY office), or, for
China Biologic

Web Site:

print email rss
© 2014 China Biologic Products, Inc. All Rights Reserved.